drugset / Trial / NCT00099346

MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)

NCT00099346

Phase 1 Terminated Merck Sharp & Dohme LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study with an investigational drug in patients with recurrent or non-responsive colorectal cancer or other advanced solid tumors. This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Timeline

Start
2005-01
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject TOZASERTIB Small molecule Other

Indications